γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-11-11
DOI
10.3389/fimmu.2014.00575
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of NKG2D ligand expression on host immune responses
- (2015) Marine Champsaur et al. IMMUNOLOGICAL REVIEWS
- The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
- (2014) Andrew Sandstrom et al. IMMUNITY
- γδ T cells for cancer immunotherapy
- (2014) Jonathan PH Fisher et al. OncoImmunology
- Critical role of butyrophilin 3A1 in presenting prenyl pyrophosphate antigens to human γδ T cells
- (2013) Dieter Kabelitz Cellular & Molecular Immunology
- Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor V 2 T lymphocytes in non-Hodgkin lymphomas
- (2013) A. Musso et al. HAEMATOLOGICA
- Butyrophilin 3A1 Plays an Essential Role in Prenyl Pyrophosphate Stimulation of Human V 2V 2 T Cells
- (2013) H. Wang et al. JOURNAL OF IMMUNOLOGY
- Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
- (2013) Stefano Vavassori et al. NATURE IMMUNOLOGY
- Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human T-cell subset
- (2012) C. Harly et al. BLOOD
- Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside
- (2012) Mounia S. Braza et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diversity of γδ T-cell antigens
- (2012) Willi K Born et al. Cellular & Molecular Immunology
- What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
- (2012) Jean-Jacques Fournié et al. Cellular & Molecular Immunology
- The Molecular Basis for Modulation of Human Vγ9Vδ2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies
- (2012) Aparna Palakodeti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy
- (2012) Volker Kunzmann et al. JOURNAL OF IMMUNOTHERAPY
- Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo
- (2012) Frances M. Richards et al. PLoS One
- Harnessing γδ T cells in anticancer immunotherapy
- (2012) Dalil Hannani et al. TRENDS IN IMMUNOLOGY
- High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas
- (2011) M. R. Zocchi et al. BLOOD
- Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
- (2011) Joshua M. Lang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Modulation of γδ T cell responses by TLR ligands
- (2011) Daniela Wesch et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
- (2010) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survival
- (2010) A. Musso et al. HAEMATOLOGICA
- Differential survival of γδT cells, αβT cells and NK cells upon engagement of NKG2D by NKG2DL-expressing leukemic cells
- (2010) Alessandro Poggi et al. INTERNATIONAL JOURNAL OF CANCER
- Phosphoantigens Overcome Human TCRV 9+ Cell Immunosuppression by TGF- : Relevance for Cancer Immunotherapy
- (2010) A.-H. Capietto et al. JOURNAL OF IMMUNOLOGY
- The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia
- (2010) H Nückel et al. LEUKEMIA
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- An six-amino acid motif in the α3 domain of MICA is the cancer therapeutic target to inhibit shedding
- (2009) Xuanjun Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies
- (2009) J. Gertner-Dardenne et al. BLOOD
- Anticancer Chemotherapy Inhibits MHC Class I-Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
- (2009) K. Kohga et al. CANCER RESEARCH
- Obstructing Shedding of the Immunostimulatory MHC Class I Chain-Related Gene B Prevents Tumor Formation
- (2009) J. D. Wu et al. CLINICAL CANCER RESEARCH
- A regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells
- (2009) Ludovic Martinet et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Rapid αβ TCR-mediated responses in γδ T cells transduced with cancer-specific TCR genes
- (2009) A Hiasa et al. GENE THERAPY
- γδ T Cells and the Lymphoid Stress-Surveillance Response
- (2009) Adrian C. Hayday IMMUNITY
- Proteasome Regulation of ULBP1 Transcription
- (2009) James E. Butler et al. JOURNAL OF IMMUNOLOGY
- Design, Synthesis, Biological Evaluation, and NMR Studies of a New Series of Arylsulfones As Selective and Potent Matrix Metalloproteinase-12 Inhibitors
- (2009) Elisa Nuti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
- (2009) A Poggi et al. LEUKEMIA
- Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
- (2008) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Associated MICA Is Shed by ADAM Proteases
- (2008) I. Waldhauer et al. CANCER RESEARCH
- Vγ9Vδ2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs—Rituximab and trastuzumab
- (2008) Hirotake Tokuyama et al. INTERNATIONAL JOURNAL OF CANCER
- NKG2D ligands in tumor immunity
- (2008) N Nausch et al. ONCOGENE
- MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma
- (2008) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer
- (2008) Jessica Pruessmeyer et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- NKG2D ligands: key targets of the immune response
- (2008) Segundo González et al. TRENDS IN IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started